Pharmsynthez Aktie
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. RUB) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 206 | 198 | 329 | 370 | 262 |
| Summe Anlagevermögen | 1 219 | 1 140 | 1 215 | 2 564 | 2 465 |
| Summe Aktiva | 1 425 | 1 338 | 1 544 | 2 934 | 2 727 |
Bilanz (in Mio. RUB) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 080 | 1 217 | 1 065 | 867 | 915 |
| Summe Eigenkapital | 345 | 121 | 479 | 2 067 | 1 813 |
| Summe Passiva | 1 425 | 1 338 | 1 544 | 2 934 | 2 727 |
Adresse
| IT Park Business Center, 197110 St. Petersburg | |
| Telefon | +7 (812) 329-8080 |
| Fax | +7 (812) 329-8089 |
| Internet | http://www.pharmsynthez.com |
Management
|
Alexander Feliksovich Lvovsky
Director |
|
Alexandra Vladimirovna Tuchkova
Production Director |
|
Alexey Andreevich Vinogradov
Director |
|
Alexey Nikolaevich Shafranov
Director, Deputy Director General-Finance |
|
Artem Vladimirovich Orlov
Deputy Director General-Corporate & Legal Affairs |
|
Daniil Akramovich Radzhabov
Director |
|
Dmitriy Dmitrievich Genkin
Executive Chairman |
|
Dmitriy Nikolayevich Poznyak
Medical Director |
|
Dmitry Vitalievich Perminov
Director |
|
Gennady Alekseevich Volkov
Director |
|
Kirill Vyacheslavovich Onokhin
Director |
|
Petr Vladimirovich Kruglyakov
Director General |
|
Roza Vasilyevna Mikhaylova
Quality Director |
|
Sergey Sergeevich Avtushenko
Director |
|
Vladimir Olegovich Kutyrov
Deputy Director General-Sales |
|
Yuliya Yurievna Yakovleva
Chief Accountant |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.